[ORAL SURVEILLANCE: what has changed in the risk assessment of JAK inhibitors?] Rubbert-Roth A. Z Rheumatol 2022;81:780-781.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rubbert-Roth A. [ORAL SURVEILLANCE: what has changed in the risk assessment of JAK inhibitors?] Z Rheumatol 2022;81:780-781.
PMID: 35960355